Voilà ce qu’est l’équité !


The Dutch Minister of Health, Mrs Edith Schippers, brought the topic to the agenda of the European Council last year. The Commission is now trying to find out whether she had a point, whether it is true that prices of pharmaceuticals aren’t fair. Lack of price transparency makes a discussion about this topic difficult. How can we discuss whether prices are fair, if those prices are secret? AIM has therefor been pleading for price transparency. But which aspects do we need to take into account when discussing whether prices of pharmaceuticals are fair? We published a paper to help answer that question. You can find it here!